Reno, Nevada – August 10, 2025
High Sierra Technologies, Inc. (“HSTI”) announces that it has received United States Patent Number 11,338,222 and that its Continuation-In-Part Application Number 17/726,860 has been allowed and a fourth United States Patent will issue shortly. In addition, HSTI has received Canadian Patent Office Patent No. 3,031,123 and European Patent Office Patent No. EP3743055 both of which are based on the Patents received in the United States by HSTI.
Now that United States Patent Number 11,338,222, Canadian Patent Office Patent No. 3,031,123, European Patent Office Patent No. EP3743055 have been formally issued and Continuation-In-Part Application Number 17/726,860 has been allowed, HSTI will continue to actively pursue the marketing and licensing of its patented and patent pending technologies in both the marijuana market spaces in the United States, Canada and the European Union as well as pursuing its own uses of its patented technologies in relation to various end user products that can benefit from the use of its patented and patent pending technologies on an international basis.
In regards to the issuance of United States Patent Number 11,338,222, Canadian Patent Office Patent No. 3,031,123, European Patent Office Patent No. EP3743055 and the allowance of Continuation-In-Part Application Number 17/726,860, Vincent C. Lombardi, President and Chief Executive Officer of HSTI, has stated that “we believe that as a result of the issuance of these Patents it will now allow HSTI to be able to more effectively control the marketplace for many types of marijuana products including low, or no, odor marijuana products in the United States, Canada and the European Union. This will allow HSTI to start generating licensing revenue from the technologies disclosed in United States Patent Numbers 10,737,198, 10,835,839, 11,338,222, Canadian Patent Office Patent No. 3,031,123 and European Patent Office Patent No. EP3743055 and the soon to be issued United States Patent based on Continuation-In-Part Application Number 17/726,860 on an international basis.”
This press release contains forward-looking statements within the meaning of the Private Securities Legislation Reform Act of 1995. The forward-looking statements may include without limitation statements regarding HSTI’s estimated revenues, gross margins, operating expenses, business models and business plans. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
HSTI is a company specializing in the development and licensing of patentable technology for use in the creation of substantially odorless and tasteless marijuana products.
HSTI trades under OTC symbol “HSTI”.
Our website may be viewed at www.high-sierra.com.
Investor Relations Contact
info@high-sierra.com
Telephone No.: 775.410.4100
Comments (0)